WHO starts initiative for Vaccine Research that facilitates research and development (R&D) against microorganisms with significant economic burden and disease, with a particular focus on low and middle income countries. Our activities span the following areas:
In the past days, the process of vaccine development occur through a series of steps that take a long period of time or many years. Now, in given the urgent need for COVID-19 vaccines, uncommon financial investments and scientific collaborations are changing how vaccines are developed.
Title : Vaccine-adjuvant nanotechnologies: Tailoring immune-interaction properties of nano particles
Giuseppe Bardi, Istituto Italiano di Tecnologia, Italy
Title : BCG an old vaccine, but still it is effective
Birger Trollfors, Birger Trollfors, Sahlgrenska University Hospital, Gothenburg, Sweden
Title : Creation of Universal Viral Vectors for Prophylactic and Therapeutic Viral and Bacterial Diseases
Chil-Yong Kang, University of Western Ontario in Canada.
Title : The pyrexia temperature never damages the cells of the brain or harm the body.
Yacob Mathai, Marma Health Centre,India
Title : Steps to Modern Conversions in use of Autogenous bacterin of Vibrio algenolyticus induce Cross-protection against Listonella anguillarum in sea bass Dicentrarchus labrax L and vice versa
Riad Hassan Khalil, Alexandria University, Egypt